Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension

Hu,Qianqian; Huang,Changquan; Wang,Yao; Wu,Renyi

doi:10.3892/mmr.2015.4287

Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension

Authors:
- Qianqian Hu
- Changquan Huang
- Yao Wang
- Renyi Wu
View Affiliations

Affiliations: Department of Glaucoma, Xiamen University Affiliated Eye Center, Xiamen, Fujian 361001, P.R. China
Published online on: September 3, 2015 https://doi.org/10.3892/mmr.2015.4287
Pages: 6577-6583
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the expression of leukemia inhibitory factor (LIF) and its downstream signaling pathways in the rat retina following acute ocular hypertension. The intraocular pressure of the rats was elevated to 110 mmHg for 1 h by infusing the anterior chamber with normal saline. The retinal tissues were obtained 12 h, 24 h, and 2, 3 and 7 days after termination of the ocular hypertension. Hematoxylin and eosin and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were performed to assess the morphological changes and the apoptosis of retinal cells, respectively. Quantification of the retinal ganglion cells (RGCs) was performed using fluorogold retrograde (FG) staining. The expression levels of LIF, LIF receptor (LIFR), signal transducers and activators of transcription 3 (STAT3), phosphorylated STAT3 (P‑STAT3), Akt, phosphorylated‑Akt (P‑Akt), extracellular signal‑regulated kinase (ERK) and phosphorylated ERK (P‑ERK) were determined at different time‑points following acute ocular hypertension using western blot analysis. Reverse transcription‑quantitative polymerase chain reaction was performned to detect the mRNA expression levels of LIF and LIFR. The results revealed that 12 h, 24 h, 2, 3 and 7 days after reperfusion, the thickness of the inner nuclear layer and the inner plexiform layer was decreased, with a significant reduction in the number of RGCs, as determined using TUNEL and FG staining. The expression levels of LIF and LIFR were increased following acute ocular hypertension. At 12 h post‑retinal reperfusion, the expression levels of P‑STAT3 and P‑Akt were significantly upregulated, while the expression of P‑ERK was decreased. The changes in the expression levels of LIF and LIFR suggested that LIF may be important in the process of degeneration/protection following retinal ischemia induced by acute ocular hypertension, via activation of the Janus kinase/STAT and Akt signaling pathways.

View Figures

View References

1	Ji JZ, Elyaman W, Yip HK, Lee VW, Yick LW and Hugon J: The possible involvement of STAT3 pathway. Eur J nerurosci. 19:265–272. 2004. View Article : Google Scholar
2	Ciotu IM, Stoian I, Gaman L, Popescu MV and Atanasiu V: Biochemical changes and treatment in glaucoma. J Med Life. 8:28–31. 2015.PubMed/NCBI
3	Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G and Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI
4	Yamauchi-Takihara K: Gp130-mediated pathway and let ventricular remodeling. J Card Fail. 8(6 Suppl): S374–S378. 2002. View Article : Google Scholar
5	Auernhammer CJ and Melmed S: Leukemia-inhibitory factor-neuroimmnue modulator of endocrine function. Endocr Rev. 21:313–345. 2000.PubMed/NCBI
6	Oh H, Fujio Y, kunisada K, Hirota H, Matsui H, Kishimoto T and Yamauchi-Takihara K: Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 s6 kinase phosphorylation in cardiac myocytes. J Biol Chem. 273:9703–9710. 1998. View Article : Google Scholar : PubMed/NCBI
7	Cheema SS, Richards L, Murphy M and Bartlett PF: Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat. J Neurosci Res. 37:213–218. 1994. View Article : Google Scholar : PubMed/NCBI
8	Mckay Hart A, Wiberg M and Terenghi G: Exogenous leukemia inhibitory factor enhances nerve regeneration after late secondary repair using a bioartificial nerve conduit. Br J plast surg. 56:444–450. 2003. View Article : Google Scholar : PubMed/NCBI
9	Gresle MM, Alexandrou E, Wu Q, Egan G, Jokubaitis V, Ayers M, Jonas A, Doherty W, Friedhuber A, Shaw G, et al: Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism. PLoS One. 7:e473792012. View Article : Google Scholar : PubMed/NCBI
10	Bürgi S, Samardziia M and Grimm C: Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration. Mol Vis. 15:1631–1637. 2009.PubMed/NCBI
11	Joly S, Lange C, Thiersch M, Samardzija M and Grimm C: Leukemia inhibitory factor extends the lifespan of injured photo-receptors in vivo. J Neurosci. 28:13765–13774. 2008. View Article : Google Scholar : PubMed/NCBI
12	Mayer M, Bhakoo K and Noble M: Ciliary nerrotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 120:143–153. 1994.PubMed/NCBI
13	Johnson EC, Doser TA, Cepurna WO, Dyck JA, Jia L, Guo Y, Lambert WS and Morrison JC: Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci. 52:504–518. 2011. View Article : Google Scholar :
14	Johnson TV and Tomarev SI: Rodent models of glaucoma. Brain Res Bull. 81:349–358. 2010. View Article : Google Scholar :
15	Metcalf D: The unsolved enigmas of leukemia inhibitory factor. Stem Cells. 21:5–14. 2003. View Article : Google Scholar : PubMed/NCBI
16	Piguet-Pellorce C, Dorval-Coiffec I, Pham MD and Jégou B: Leukemia inhibitory factor expression and regulation within the testis. Endocrinonlogy. 141:1136–1141. 2000. View Article : Google Scholar
17	Sariola H: The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci. 58:1061–1066. 2001. View Article : Google Scholar : PubMed/NCBI
18	Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA and Gough NM: Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 336:684–687. 1988. View Article : Google Scholar : PubMed/NCBI
19	Smith AG, Health JK, Donaldson DD, Wong GG, Moreau J, Stahl M and Rogers D: Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 336:688–690. 1988. View Article : Google Scholar : PubMed/NCBI
20	Reid LR, Lowe C, Cornish J, Skinner SJ, Hilton DJ, Willson TA, Gearing DP and Martin TJ: Leukemia inhibitory factor: A novel bone-active cytokine. Endocrinology. 126:1416–1420. 1990. View Article : Google Scholar : PubMed/NCBI
21	Dazai S, Akita S, Hirano A, Rashid MA, Naito S, Akino K and Fujii T: Leukemia inhibitory factor enhances bone formation in calvarial bone defect. J Craniofac Srug. 11:513–520. 2000. View Article : Google Scholar
22	Dowsing BJ, Hayes A, Bennett TM, Morrison WA and Messina A: Effects of LIF dose and laminin plus fibronectin on axotomized sciatic nerves. Muscle Nerve. 23:1356–1364. 2000. View Article : Google Scholar : PubMed/NCBI
23	Cafferty WB, Gardiner NJ, Gavazzi I, Powell J, McMahon SB, Heath JK, Munson J, Cohen J and Thompson SW: Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci. 21:7161–7170. 2001.PubMed/NCBI
24	Bauer S, Rasika S, Han J, Mauduit C, Raccurt M, Morel G, Jourdan F, Benahmed M, Moyse E and Patterson PH: Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium. J Neurosci. 23:1792–1803. 2003.PubMed/NCBI
25	Pan S, Li L, Xu Z and Zhao J: Effect of leukemia inhibitory factor on corneal nerve regeneration of rabbit eyes after laser in situ keratomileusis. Neurosci Lett. 499:99–103. 2011. View Article : Google Scholar : PubMed/NCBI
26	Chollangi S, Wang J, Martin A, Quinn J and Ash JD: Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol Dis. 34:535–544. 2009. View Article : Google Scholar : PubMed/NCBI
27	Ueki Y, Le YZ, Chollangi S, Muller W and Ash JD: Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors. Proc Natl Acad Sci USA. 106:21389–21394. 2009. View Article : Google Scholar : PubMed/NCBI
28	Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY and Yancopoulos GD: LIRR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 260:1805–1808. 1993. View Article : Google Scholar : PubMed/NCBI
29	Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF and Wood WI: Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 270:10915–10922. 1995.PubMed/NCBI
30	Gearing DP and Bruce AG: Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biol. 4:61–65. 1992.PubMed/NCBI
31	Plun-Favreau H, Perret D, Diveu C, Froger J, Chevalier S, Lelièvre E, Gascan H and Chabbert M: Leukemia inhibitory factor (LIF), cardiotrophin-1 and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J Biol Chem. 278:27169–27179. 2003. View Article : Google Scholar : PubMed/NCBI
32	Ju WK, Lee MY, Hofmann HD, Kirsch M, Oh SJ, Chung JW and Chun MH: Increased expression of ciliary neurotrophic factor receptor alpha mRNA in the ischemic rat retina. Neurosci Lett. 283:133–136. 2000. View Article : Google Scholar : PubMed/NCBI
33	Jomary C, Cullen J and Jones SE: Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse. Invest Ophthalmol Vis Sci. 47:1620–1629. 2006. View Article : Google Scholar : PubMed/NCBI
34	Hideshima T, Nakamura N, Chauhan D and Anderson KC: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene. 20:5991–6000. 2001. View Article : Google Scholar : PubMed/NCBI
35	Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao YH, Chu CY and Kuo ML: The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. J Invest Dermatol. 119:1121–1127. 2002. View Article : Google Scholar : PubMed/NCBI
36	Chen J, Fujii K, Zhang L, Roberts T and Fu H: Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA. 98:7783–7788. 2001. View Article : Google Scholar : PubMed/NCBI
37	Sweatt JD: The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem. 76:1–10. 2001. View Article : Google Scholar : PubMed/NCBI
38	Roth S, Shaikh AR, Hennelly MM, Li Q, Bindokas V and Graham CE: Mitogen-activated protein kinases and retinal ischemia. Invest Ophthalmol Vis Sci. 44:5383–5395. 2003. View Article : Google Scholar : PubMed/NCBI
39	Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV and Alessandrini A: Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA. 98:11569–11574. 2001. View Article : Google Scholar : PubMed/NCBI